Modulation of cytarabine induced cytotoxicity using novel deoxynucleoside analogs in the HL60 cell line

被引:8
作者
Hubeek, I [1 ]
Peters, GJ
Broekhuizen, AJF
Kaspers, GJL
机构
[1] VU Univ, Ctr Med, Dept Pediat Hematol Oncol, Amsterdam, Netherlands
[2] VU Univ, Ctr Med, Dept Med Oncol, Amsterdam, Netherlands
关键词
cytarabine; deoxynucleoside analogs; modulation;
D O I
10.1081/NCN-200027727
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
In order to enhance the cytotoxicity of ara-C in the HL60 cell line the following deoxynucleoside analogs were used: cladribine, fludarabine and gemcitabine. HL60 cells were co-incubated with ara-C and each of the modulators at the ratios of their respective IC50s. Cytotoxicity was determined with the MTT-assay and drug interactions were evaluated with the combination index (CI) method (Calcusyn; Chou & Talalay). CI < 1, CI +/- 1 and >1 indicate synergism, additive effect and antagonism, respectively. We observed moderate synergism between ara-C/cladribine and ara-C/ gemcitabine, with CIs of 0.76 +/- 0.14 and 0.82 +/- 0.04, respectively. The interaction between ara-C/fludarabine resulted in moderate antagonism (CI = 1.29 +/- 0.11). In conclusion, in this in vitro study we showed that the cytotoxicity of ara-C can be succesfully modulated in the HL60 cell line by cladribine and gemcitabine.
引用
收藏
页码:1513 / 1516
页数:4
相关论文
共 15 条
[1]
QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[2]
CORY JG, 1983, MOL CELL BIOCHEM, V53-4, P257
[3]
ESTEY E, 1987, LEUKEMIA, V1, P580
[4]
Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: Pharmacokinetic, pharmacodynamic, and molecular interactions [J].
Gandhi, V ;
Estey, E ;
Keating, MJ ;
Chucrallah, A ;
Plunkett, W .
BLOOD, 1996, 87 (01) :256-264
[5]
GANDHI V, 1992, CANCER RES, V52, P897
[6]
Grant S, 1998, ADV CANCER RES, V72, P197
[7]
Iwasaki H, 1997, BLOOD, V90, P270
[8]
Cellular drug resistance in acute myeloid leukemia:: literature review and preliminary analysis of an ongoing collaborative study [J].
Kaspers, CJL ;
Zwaan, CM ;
Veerman, AJP ;
Rots, MG ;
Pieters, R ;
Bucsky, P ;
Domula, M ;
Göbel, U ;
Graf, N ;
Havers, W ;
Jorch, N ;
Kabisch, K ;
Spaar, HJ ;
Ritter, J ;
Creutzig, U .
KLINISCHE PADIATRIE, 1999, 211 (04) :239-244
[9]
INVITRO DRUG SENSITIVITY OF NORMAL PERIPHERAL-BLOOD LYMPHOCYTES AND CHILDHOOD LEUKEMIC-CELLS FROM BONE-MARROW AND PERIPHERAL-BLOOD [J].
KASPERS, GJL ;
PIETERS, R ;
VANZANTWIJK, CH ;
DELAAT, PAJM ;
DEWAAL, FC ;
VANWERING, ER ;
VEERMAN, AJP .
BRITISH JOURNAL OF CANCER, 1991, 64 (03) :469-474
[10]
PLUNKETT W, 1993, SEMIN ONCOL, V20, P50